John Reeder
Director/Miembro de la Junta en Drugs for Neglected Diseases initiative .
Perfil
John Reeder is currently the Director at Drugs for Neglected Diseases initiative.
Previously, he worked as the Director-Population Health Center at The Macfarlane Burnet Institute For Medical Research & Public.
He holds a doctorate degree from The University of Manchester.
Cargos activos de John Reeder
| Empresas | Cargo | Inicio |
|---|---|---|
Drugs for Neglected Diseases initiative
 Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de John Reeder.
| Empresas | Cargo | Fin |
|---|---|---|
The Macfarlane Burnet Institute For Medical Research & Public
 The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Corporate Officer/Principal | - |
Formación de John Reeder.
| The University of Manchester | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
The Macfarlane Burnet Institute For Medical Research & Public
The Macfarlane Burnet Institute For Medical Research & Public Miscellaneous Commercial ServicesCommercial Services The Macfarlane Burnet Institute For Medical Research & Public Health Ltd. provides medical research and public health services. Its programs include maternal health, disease elimination, behaviors and health risks, health security, and healthy ageing. The organization also focuses on women's and children's health; alcohol, other drugs and harm reduction; sexual and reproductive health; and young people's health. The organization was founded in 1986 headquartered in Melbourne, Australia. | Commercial Services |
- Bolsa de valores
- Insiders
- John Reeder
